Search - tctmd.com

Displaying 1 - 20 of 258

Sort: Relevancy | Date

News Conference News ACC 2026

Oral PCSK9 Inhibitor Bests Other Nonstatin Therapies for LDL-Lowering

Michael O'Riordan

April 01, 2026

News Daily News

Genomics, Lipids, Inflammation at Midlife Predict Future CAD

Caitlin E. Cox

March 25, 2026

News Daily News

Lp(a) and CAC Levels Independently Predict Long-term ASCVD Risk

Yael L. Maxwell

March 19, 2026

News Daily News

Lower LDL Levels, Starting Earlier in Life: New ACC/AHA Dyslipidemia Guidelines

Michael O'Riordan

March 13, 2026

News Daily News

Lp(a) Linked to 30-Year CVD Risk in Healthy Women

Michael O'Riordan

January 09, 2026

News Daily News

Year in Review: Top Prevention Stories of 2025

Michael O'Riordan

December 24, 2025

News Features

Year in Review: Women’s Heart Health in the Spotlight

Caitlin E. Cox

December 23, 2025

News Opinion CV Team Dispatch

November 2025 Dispatch for the CV Team

L.A. McKeown

November 24, 2025

News Conference News AHA 2025

Oral PCSK9 Inhibitor Enlicitide Cuts LDL Cholesterol: CORALreef Lipids

Michael O'Riordan

November 10, 2025

News Conference News AHA 2025

Triple Agonist Appears Promising for Patients With Severe Hypertriglyceridemia

Caitlin E. Cox

November 08, 2025

News Conference News AHA 2025

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

Todd Neale

November 08, 2025

Presentation TCT 2025

TCT 497: Combined Assessment of Lipoprotein(a) and Non-Culprit Coronary LesionSeverity on Clinical Outcomes in Acute Coronary Syndrome

Presenter: Hirokazu Tanaka

October 28, 2025

Presentation TCT 2025

TCT 486: Lipoprotein(a) as a Predictor of Lesion Complexity in Patients undergoing Elective Percutaneous Coronary Intervention : Insights from an Asian single center cohort

Presenter: Melly Susanti

October 27, 2025

Presentation TCT 2025

TCT 485: Lipoprotein(a) and Long-Term Cardiovascular Events in Patients With Coronary Vasospasm

Presenter: Melly Susanti

October 27, 2025

Presentation TCT 2025

TCT 480: Imparied high-density lipoprotein functionality assessed by cholesterol uptake capacity might cause plaque vulnerability and unfavorable prognosis after percutaneous coronary intervention.

Presenter: Kotaro Higuchi

October 27, 2025

Presentation TCT 2025

TCT 475: Impact of Elevated Lipoprotein(a) on LDL Cholesterol Target Attainment Following PCI for Acute Coronary Syndrome Despite Intensive Triple Oral Lipid-Lowering Therapy: A Retrospective Cohort Study

Presenter: Kunal Mahajan

October 27, 2025

Presentation TCT 2025

TCT 1241: Atherogenic Lipoproteins and Intraplaque Lipid Burden: Evidence from NIRS-IVUS in Statin-Naive Patients

Presenter: Woohyeun Kim

October 26, 2025

News Opinion CV Team Dispatch

October 2025 Dispatch for the CV Team

L.A. McKeown

October 25, 2025

News Daily News

Biomarkers Added to a Polygenic Risk Score Equals Better CAD Prediction

Yael L. Maxwell

October 23, 2025

News Conference News ESC 2025

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Michael O'Riordan

September 10, 2025

Advertisement

Oral PCSK9 Inhibitor Bests Other Nonstatin Therapies for LDL-Lowering

Genomics, Lipids, Inflammation at Midlife Predict Future CAD

Lp(a) and CAC Levels Independently Predict Long-term ASCVD Risk

Lower LDL Levels, Starting Earlier in Life: New ACC/AHA Dyslipidemia Guidelines

Lp(a) Linked to 30-Year CVD Risk in Healthy Women

Year in Review: Top Prevention Stories of 2025

Year in Review: Women’s Heart Health in the Spotlight

November 2025 Dispatch for the CV Team

Oral PCSK9 Inhibitor Enlicitide Cuts LDL Cholesterol: CORALreef Lipids

Triple Agonist Appears Promising for Patients With Severe Hypertriglyceridemia

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

TCT 497: Combined Assessment of Lipoprotein(a) and Non-Culprit Coronary LesionSeverity on Clinical Outcomes in Acute Coronary Syndrome

TCT 486: Lipoprotein(a) as a Predictor of Lesion Complexity in Patients undergoing Elective Percutaneous Coronary Intervention : Insights from an Asian single center cohort

TCT 485: Lipoprotein(a) and Long-Term Cardiovascular Events in Patients With Coronary Vasospasm

TCT 480: Imparied high-density lipoprotein functionality assessed by cholesterol uptake capacity might cause plaque vulnerability and unfavorable prognosis after percutaneous coronary intervention.

TCT 475: Impact of Elevated Lipoprotein(a) on LDL Cholesterol Target Attainment Following PCI for Acute Coronary Syndrome Despite Intensive Triple Oral Lipid-Lowering Therapy: A Retrospective Cohort Study

TCT 1241: Atherogenic Lipoproteins and Intraplaque Lipid Burden: Evidence from NIRS-IVUS in Statin-Naive Patients

October 2025 Dispatch for the CV Team

Biomarkers Added to a Polygenic Risk Score Equals Better CAD Prediction

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content